RecruitingNot ApplicableNCT05904340

Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy

The Efficacy of Social Media Assisted Home-based Transcutaneous Electrical Acupoint Stimulation on Symptoms Associated with Chemotherapy Induced Peripheral Neuropathy in Patients with Breast Cancer

Sponsor

National Taipei University of Nursing and Health Sciences

Enrollment

86 participants

Start Date

Jul 1, 2023

Study Type

INTERVENTIONAL

Conditions

Breast Neoplasms

Summary

Breast cancer ranks first in Taiwan's top ten gynecological cancers. Chemotherapy is a standard treatment method for colorectal cancer and breast cancer, but while destroying cancer cells, it also destroys healthy cells, resulting in side effects. Peripheral neuropathy can lead to peripheral nerve damage and decreased activity, which affects the patient's quality of life. Currently, there is no standard and effective method for treating peripheral neuropathy caused by chemotherapy. Therefore, the purpose of this study is to investigate the effect of percutaneous electrical acupoint stimulation on improving peripheral nerve symptoms in breast cancer patients undergoing chemotherapy.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a type of electrical acupoint stimulation (applying gentle electrical pulses to specific points on the skin, similar to acupuncture) can help relieve nerve pain and numbness caused by chemotherapy (a side effect called chemotherapy-induced peripheral neuropathy) in breast cancer patients in Taiwan. **You may be eligible if...** - You were first diagnosed with breast cancer and have completed chemotherapy (paclitaxel, vinblastine, or platinum drugs) within the past 3 months - You still have ongoing nerve symptoms (numbness, tingling, pain) after finishing chemotherapy - Your nerve damage is rated grade 2 or higher - You are able to communicate in Mandarin or Taiwanese **You may NOT be eligible if...** - Your cancer has spread to other parts of the body (stage IV or metastatic) - You are currently taking duloxetine for nerve pain - You are already receiving acupoint stimulation therapy - You have a cardiac pacemaker - You have diabetic nerve damage or nerve damage from HIV/AIDS - You are currently being treated for a mental health condition Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETranscutaneous Electrical Nerve Stimulation

Transcutaneous Electrical Nerve Stimulation (TENS) uses machines to generate electric current, flows through the skin and conducts to the nerves, triggers a chain reaction of nerves through a new stimulus source, and achieves the effect of pain relief. Using different frequencies and intensities will Produce different effects and trigger different physiological mechanisms.